BioXcel Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New Haven, CT
SEC filing record 1 source field available
Fiscal year end
31 December
BioXcel Therapeutics, Inc. has filed 656 SEC EDGAR filings since 13 Nov 2017

SEC filing history

Showing 476-500 of 656 matching filings.

Per page
25
Current page
20
SC 13G/A File 005-90437

SC 13G/A filing

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
28 Jan 2021
Reporting date
28 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Jan 2021
Reporting date
25 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Jan 2021
Reporting date
19 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
14 Jan 2021
Reporting date
14 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Dec 2020
Reporting date
28 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
12 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
14 Aug 2020
Reporting date
14 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
31 Jul 2020
Reporting date
28 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-240118

424B5

Filing date
30 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-240118

424B5

Filing date
27 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-240118

S-3ASR

Filing date
27 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
27 Jul 2020
Reporting date
27 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38410

FORM 8-K

Filing date
24 Jun 2020
Reporting date
24 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
23 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
23 Jun 2020
Reporting date
22 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
17 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 May 2020
Reporting date
26 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .